EyeContactDX Appoints Dr. Carol Weitzman as Senior Strategic Advisor for AI Autism Screening

EyeContactDX has appointed Dr. Carol Weitzman, a leading developmental-behavioral pediatrician, as Senior Strategic Advisor to advance its AI-driven autism spectrum disorder (ASD) screening technology, announced in a press release.

Dr. Weitzman, known for her work in shaping ASD care guidelines, will guide EyeContactDX as it scales its eye-tracking screening solution for primary care use. The company’s platform applies AI and computer vision to detect visual biomarkers related to ASD using standard commercial tablets, eliminating the need for specialized hardware or trained operators.

EyeContactDX’s technology aims to provide pediatricians with an objective, accessible screening tool that integrates into existing clinical workflows. The company is preparing for deployments across key U.S. markets to support earlier detection and intervention for children at risk of ASD.